CLK3 antibody
Principal name
CLK3 antibody
Alternative names for CLK3 antibody
CDC-like kinase 3, Dual specificity protein kinase CLK3
Ncbi ID
9606, NP_001123500.1, NM_003992.3, AAH02555.1, NM_003992, NP_031739.3, BC085084, NM_007713, NM_001130028
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P), Immunocytochemistry/Immunofluorescence (ICC/IF), ELISA (detection) (E(detection))
Background of CLK3 antibody
- Kit Component:
- - KN303471G1, Clk3 gRNA vector 1 in pCas-Guide vector
- KN303471G2, Clk3 gRNA vector 2 in pCas-Guide vector
- KN303471D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Immunoperoxidase of monoclonal antibody to CLK3 on formalin-fixed paraffin-embedded human placenta. [antibody concentration 0.2 ug/ml]
CLK3 monoclonal antibody (M01), clone 1H2 Western Blot analysis of CLK3 expression in Hela NE ( Cat # L013V3 ).
CLK3 monoclonal antibody (M01), clone 1H2. Western Blot analysis of CLK3 expression in PC-12(Cat # L012V1 ).
Immunoperoxidase of monoclonal antibody to CLK3 on formalin-fixed paraffin-embedded human testis. [antibody concentration 1.5 ug/ml]
Immunofluorescence of monoclonal antibody to CLK3 on HeLa cell. [antibody concentration 10 ug/ml]
CLK3 monoclonal antibody (M04), clone 5B2 Western Blot analysis of CLK3 expression in MCF-7 ( Cat # L046V1 ).
Immunoperoxidase of monoclonal antibody to CLK3 on formalin-fixed paraffin-embedded human placenta. [antibody concentration 0.5 ug/ml]
Immunofluorescence of monoclonal antibody to CLK3 on HeLa cell. [antibody concentration 8 ug/ml]
Western blot analysis of CLK3 over-expressed 293 cell line, cotransfected with CLK3 Validated Chimera RNAi ( Cat # H00001198-R01V ) (Lane 2) or non-transfected control (Lane 1). Blot probed with CLK3 monoclonal antibody (M05) clone 1F10 (Cat # H00001198-M05 ). GAPDH ( 36.1 kDa ) used as specificity and loading control.
CLK3 monoclonal antibody (M05), clone 1F10 Western Blot analysis of CLK3 expression in Hela NE ( Cat # L013V3 ).
Western Blot analysis of CLK3 expression in transfected 293T cell line by CLK3 monoclonal antibody (M05), clone 1F10.Lane 1: CLK3 transfected lysate(58.6 KDa).Lane 2: Non-transfected lysate.
Immunoperoxidase of monoclonal antibody to CLK3 on formalin-fixed paraffin-embedded human prostate. [antibody concentration 3 ug/ml]
Immunofluorescence of monoclonal antibody to CLK3 on HeLa cell. [antibody concentration 10 ug/ml]
CLK3 monoclonal antibody (M07), clone 7D6 Western Blot analysis of CLK3 expression in MCF-7 ( Cat # L046V1 ).
CLK3 monoclonal antibody (M07), clone 7D6 Western Blot analysis of CLK3 expression in MCF-7 ( Cat # L046V1 ).
Western Blot analysis of CLK3 expression in transfected 293T cell line (H00001198-T01) by CLK3 MaxPab polyclonal antibody.Lane 1: CLK3 transfected lysate(53.9 KDa).Lane 2: Non-transfected lysate.
CLK3 monoclonal antibody (M02), clone 3C11 Western Blot analysis of CLK3 expression in Hela NE ( Cat # L013V3 ).
Lysates
| Catalog No. | ||
|---|---|---|
| LY418305 | CLK3 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR207842L2V | Lenti ORF particles, Clk3 (GFP-tagged) - Mouse CDC-like kinase 3 (cDNA clone MGC:103028 IMAGE:6309020), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,240.00
|
|
| OriGene Technologies, Inc. | ||
| MR220586L2V | Lenti ORF particles, Clk3 (GFP-tagged) - Mouse CDC-like kinase 3 (Clk3), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,380.00
|
|
| OriGene Technologies, Inc. | ||
| MR207842L1V | Lenti ORF particles, Clk3 (Myc-DDK-tagged) - Mouse CDC-like kinase 3 (cDNA clone MGC:103028 IMAGE:6309020), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||
| MR220586L1V | Lenti ORF particles, Clk3 (Myc-DDK-tagged) - Mouse CDC-like kinase 3 (Clk3), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,240.00
|
|
| OriGene Technologies, Inc. | ||